https://www.cureus.com/articles/110707-role-of-ertugliflozin-in-the-management-of-diabetes-mellitus
0
0
11/12/22 at 12:55pm
Organization
Cureus.com
Authors
The novel oral sodium-glucose cotransporter-2 (SGLT2) inhibitor Ertugliflozin (SteglatroTM) is introduced as a monotherapy or in conjunction with another antidiabetic drug regimen for the treatment of type 2 diabetes mellitus (T2DM). Additional safe and effic…
Create an account
or login to join the discussion